Mark Mallon
2021
In 2021, Mark Mallon earned a total compensation of $170.6K as Former Chief Executive Officer at Ironwood Pharmaceuticals, a 97% decrease compared to previous year.
Compensation breakdown
| Salary | $163,413 |
|---|---|
| Other | $7,163 |
| Total | $170,576 |
Mallon received $163.4K in salary, accounting for 96% of the total pay in 2021.
Mallon also received $7.2K in other compensation.
Rankings
In 2021, Mark Mallon's compensation ranked 12,070th out of 12,415 executives tracked by ExecPay. In other words, Mallon earned more than 2.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 12,070 out of 12,415 | 3rd |
Division Manufacturing | 5,339 out of 5,505 | 3rd |
Major group Chemicals And Allied Products | 2,324 out of 2,375 | 2nd |
Industry group Drugs | 2,055 out of 2,096 | 2nd |
Industry Pharmaceutical Preparations | 1,518 out of 1,546 | 2nd |
Source: SEC filing on April 21, 2022.
Mallon's colleagues
We found six more compensation records of executives who worked with Mark Mallon at Ironwood Pharmaceuticals in 2021.
2021
Thomas McCourt
Ironwood Pharmaceuticals
Chief Executive Officer
2021
Jason Rickard
Ironwood Pharmaceuticals
Chief Operating Officer
2021
John Minardo
Ironwood Pharmaceuticals
Chief Legal Officer
2021
Gina Consylman
Ironwood Pharmaceuticals
Chief Financial Officer
2021
Michael Shetzline
Ironwood Pharmaceuticals
Chief Medical Officer
2021
Sravan Emany
Ironwood Pharmaceuticals